What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Surgery
Mario Tumbarello mostly deals with Internal medicine, Retrospective cohort study, Bacteremia, Surgery and Mortality rate.
His Internal medicine research integrates issues from Klebsiella pneumoniae and Intensive care medicine.
The study incorporates disciplines such as Drug resistance and Cohort in addition to Retrospective cohort study.
His Bacteremia research is multidisciplinary, relying on both Epidemiology, Antimicrobial, Neutropenia and Risk factor.
His work carried out in the field of Mortality rate brings together such families of science as Candida glabrata, Immunology and Candida tropicalis.
His studies deal with areas such as Carbapenem and Confidence interval as well as Odds ratio.
His most cited work include:
- Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy (670 citations)
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment (349 citations)
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study (308 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Surgery, Immunology, Intensive care medicine and Bacteremia.
His study in Mortality rate, Retrospective cohort study, Neutropenia, Septic shock and Incidence are all subfields of Internal medicine.
His biological study spans a wide range of topics, including Odds ratio, Cohort study and Cohort.
His study looks at the relationship between Surgery and fields such as Risk factor, as well as how they intersect with chemical problems.
His work on Intensive care unit and Critically ill as part of general Intensive care medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His Bacteremia research includes elements of Pseudomonas aeruginosa, Klebsiella pneumoniae and Methicillin-resistant Staphylococcus aureus.
He most often published in these fields:
- Internal medicine (54.55%)
- Surgery (20.25%)
- Immunology (19.83%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (54.55%)
- Septic shock (12.81%)
- Intensive care medicine (18.18%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Septic shock, Intensive care medicine, Bacteremia and Mortality rate.
His Internal medicine study combines topics in areas such as Gastroenterology and Klebsiella pneumoniae.
His Septic shock study incorporates themes from Odds ratio, Clinical endpoint, Renal replacement therapy and Retrospective cohort study.
His studies in Intensive care medicine integrate themes in fields like MEDLINE and Abdominal Infection.
Mario Tumbarello has researched Bacteremia in several fields, including Staphylococcal infections, Methicillin-resistant Staphylococcus aureus and Pneumonia.
His work deals with themes such as Antimicrobial susceptibility, Prospective cohort study and Urinary system, which intersect with Mortality rate.
Between 2017 and 2021, his most popular works were:
- Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae. (110 citations)
- Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. (62 citations)
- Ceftolozane/tazobactam: place in therapy. (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Disease
The scientist’s investigation covers issues in Internal medicine, Septic shock, Bacteremia, Antibiotics and Enterobacteriaceae.
His study in Internal medicine is interdisciplinary in nature, drawing from both Carbapenem-resistant enterobacteriaceae, Klebsiella pneumoniae and Acinetobacter baumannii.
His Septic shock study integrates concerns from other disciplines, such as Odds ratio, Clinical endpoint and Retrospective cohort study.
Mario Tumbarello studied Retrospective cohort study and Intensive care that intersect with Incidence and Intensive care unit.
His research investigates the connection with Bacteremia and areas like Pneumonia which intersect with concerns in Drug, Safety profile, Intensive care medicine and Ceftobiprole.
Mario Tumbarello has included themes like Microbiology and Cephalosporin in his Enterobacteriaceae study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
